ATHIRA PHARMA INC (ATHA) Stock Earnings & Estimates
USA - NASDAQ:ATHA - US04746L1044 - Common Stock
3.83 USD
+0.05 (+1.32%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | -63.54M -98.44% | -93.17M -46.63% | -126.125M -35.37% | -95.805M 24.04% | N/A 26.17% | N/A -4.84% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.01M | -5.45M -8.78% | -20M -266.97% | -64.02M -220.10% | -94.02M -46.86% | -127.094M -35.18% | -96.775M 23.86% | N/A 73.07% | N/A -2.35% | N/A -10.52% | N/A -121.80% | N/A -30.42% | N/A -26.91% | N/A 44.39% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.50 11.76% | -2.27 -51.33% | -3.09 -36.12% | -2.53 18.12% | N/A 71.60% | N/A 41.42% | N/A 72.13% | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 83.41% | -0.10 73.45% | -0.19 15.74% | -0.06 66.00% | -0.05 59.02% | -0.05 50.74% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.488M 82.40% | -3.264M 79.03% | -7.854M 17.64% | -7.854M -7.72% | -7.854M -75.00% | -7.854M -140.63% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.18 74.29% | -0.18 | 0.00 | 1.96% |
| Q1 2025 Q2Q % growth | -0.23 66.67% | -0.24 | 0.01 | 6.05% |
| Q4 2024 Q2Q % growth | -0.39 45.07% | -0.45 | 0.06 | 13.23% |
| Q3 2024 Q2Q % growth | -0.75 13.79% | -0.72 | -0.03 | -4.12% |
| Q2 2024 Q2Q % growth | -0.70 10.26% | -0.75 | 0.05 | 6.86% |
| Q1 2024 Q2Q % growth | -0.69 5.48% | -0.81 | 0.12 | 14.42% |
| Q4 2023 Q2Q % growth | -0.71 -33.96% | -0.98 | 0.27 | 27.47% |
| Q3 2023 Q2Q % growth | -0.87 -64.15% | -0.83 | -0.04 | -4.78% |
| Q2 2023 Q2Q % growth | -0.78 -20.00% | -0.80 | 0.02 | 2.36% |
| Q1 2023 Q2Q % growth | -0.73 -30.36% | -0.64 | -0.09 | -14.69% |
| Q4 2022 Q2Q % growth | -0.53 -17.78% | -0.68 | 0.15 | 22.45% |
| Q3 2022 Q2Q % growth | -0.53 -26.19% | -0.65 | 0.12 | 17.96% |
| Q2 2022 Q2Q % growth | -0.65 -71.05% | -0.65 | 0.00 | 0.17% |
| Q1 2022 Q2Q % growth | -0.56 -124.00% | -0.56 | 0.00 | 0.18% |
| Q4 2021 Q2Q % growth | -0.45 -87.50% | -0.55 | 0.10 | 18.30% |
| Q3 2021 Q2Q % growth | -0.42 62.50% | -0.51 | 0.09 | 17.09% |
| Q2 2021 Q2Q % growth | -0.38 | -0.35 | -0.03 | -7.99% |
| Q1 2021 Q2Q % growth | -0.25 | -0.31 | 0.06 | 18.98% |
| Q4 2020 Q2Q % growth | -0.24 | -0.40 | 0.16 | 40.68% |
| Q3 2020 Q2Q % growth | -1.12 | -0.26 | -0.87 | -339.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2020 Q2Q % growth | 68.003K | -68.003K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 17.01% | 28.24% | 5.44% | 5.44% |
| Revenue | N/A | N/A | N/A | N/A |